144 related articles for article (PubMed ID: 2847294)
1. Ganciclovir treatment of serious cytomegalovirus infection in heart and heart-lung transplant recipients.
Keay S; Petersen E; Icenogle T; Zeluff BJ; Samo T; Busch D; Newman CL; Buhles WC; Merigan TC
Rev Infect Dis; 1988; 10 Suppl 3():S563-72. PubMed ID: 2847294
[TBL] [Abstract][Full Text] [Related]
2. Ganciclovir therapy for cytomegalovirus disease associated with renal transplants.
Snydman DR
Rev Infect Dis; 1988; 10 Suppl 3():S554-62. PubMed ID: 2847293
[TBL] [Abstract][Full Text] [Related]
3. Ganciclovir therapy for cytomegalovirus infections in recipients of bone marrow transplants and other immunosuppressed patients.
Winston DJ; Ho WG; Bartoni K; Holland GN; Mitsuyasu RT; Gale RP; Busuttil RW; Champlin RE
Rev Infect Dis; 1988; 10 Suppl 3():S547-53. PubMed ID: 2847292
[TBL] [Abstract][Full Text] [Related]
4. Ganciclovir treatment of life- or sight-threatening cytomegalovirus infection: experience in 314 immunocompromised patients.
Buhles WC; Mastre BJ; Tinker AJ; Strand V; Koretz SH
Rev Infect Dis; 1988; 10 Suppl 3():S495-506. PubMed ID: 2847286
[TBL] [Abstract][Full Text] [Related]
5. Ganciclovir treatment of cytomegalovirus disease in transplant recipients and other immunocompromised hosts.
Erice A; Jordan MC; Chace BA; Fletcher C; Chinnock BJ; Balfour HH
JAMA; 1987 Jun; 257(22):3082-7. PubMed ID: 3035246
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cytomegalovirus pneumonitis with ganciclovir in renal transplantation.
Stoffel M; Pirson Y; Squifflet JP; Lamy M; Gianello P; Alexandre GP
Transpl Int; 1988 Dec; 1(4):181-5. PubMed ID: 2855305
[TBL] [Abstract][Full Text] [Related]
7. DHPG effectively treats CMV infection in heart and heart-lung transplant patients: a preliminary report.
Icenogle TB; Peterson E; Ray G; Minnich L; Copeland JG
J Heart Transplant; 1987; 6(4):199-203. PubMed ID: 2822880
[TBL] [Abstract][Full Text] [Related]
8. Gastrointestinal cytomegalovirus infection in heart and heart-lung transplant recipients.
Kaplan CS; Petersen EA; Icenogle TB; Copeland JG; Villar HV; Sampliner R; Minnich L; Ray CG
Arch Intern Med; 1989 Sep; 149(9):2095-100. PubMed ID: 2549896
[TBL] [Abstract][Full Text] [Related]
9. Cytomegalovirus infections in heart and heart-lung transplant recipients.
Wreghitt T
J Antimicrob Chemother; 1989 Jun; 23 Suppl E():49-60. PubMed ID: 2550412
[TBL] [Abstract][Full Text] [Related]
10. Treatment of cytomegalovirus pneumonia.
Crumpacker C; Marlowe S; Zhang JL; Abrams S; Watkins P
Rev Infect Dis; 1988; 10 Suppl 3():S538-46. PubMed ID: 2847291
[TBL] [Abstract][Full Text] [Related]
11. Treatment and prophylaxis of cytomegalovirus disease.
Levinson ML; Jacobson PA
Pharmacotherapy; 1992; 12(4):300-18. PubMed ID: 1325636
[TBL] [Abstract][Full Text] [Related]
12. Intravenous ganciclovir prophylaxis for cytomegalovirus in heart, heart-lung, and lung transplant recipients.
Wreghitt TG; Abel SJ; McNeil K; Parameshwar J; Stewart S; Cary N; Sharples L; Large S; Wallwork J
Transpl Int; 1999; 12(4):254-60. PubMed ID: 10460870
[TBL] [Abstract][Full Text] [Related]
13. Treatment of cytomegalovirus pneumonia in heart transplant recipients with 9(1,3-dihydroxy-2-proproxymethyl)-guanine (DHPG).
Watson FS; O'Connell JB; Amber IJ; Renlund DG; Classen D; Johnston JM; Smith CB; Bristow MR
J Heart Transplant; 1988; 7(2):102-5. PubMed ID: 2835468
[TBL] [Abstract][Full Text] [Related]
14. Prevention of primary cytomegalovirus disease in organ transplant recipients with oral ganciclovir or oral acyclovir prophylaxis.
Rubin RH; Kemmerly SA; Conti D; Doran M; Murray BM; Neylan JF; Pappas C; Pitts D; Avery R; Pavlakis M; Del Busto R; DeNofrio D; Blumberg EA; Schoenfeld DA; Donohue T; Fisher SA; Fishman JA
Transpl Infect Dis; 2000 Sep; 2(3):112-7. PubMed ID: 11429021
[TBL] [Abstract][Full Text] [Related]
15. Cytomegalovirus infections in renal, heart, heart-lung and liver transplantation.
Pollard RB
Pediatr Infect Dis J; 1988 May; 7(5 Suppl):S97-102. PubMed ID: 2456512
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ganciclovir for cytomegalovirus disease.
Fletcher CV; Balfour HH
DICP; 1989 Jan; 23(1):5-12. PubMed ID: 2541566
[TBL] [Abstract][Full Text] [Related]
17. Ganciclovir treatment of cytomegalovirus infections in iatrogenically immunocompromised patients.
Keay S; Bissett J; Merigan TC
J Infect Dis; 1987 Dec; 156(6):1016-21. PubMed ID: 2824621
[No Abstract] [Full Text] [Related]
18. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.
Gerbase MW; Dubois D; Rothmeier C; Spiliopoulos A; Wunderli W; Nicod LP
Chest; 1999 Nov; 116(5):1265-72. PubMed ID: 10559085
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus retinitis and response to therapy with ganciclovir.
Henderly DE; Freeman WR; Causey DM; Rao NA
Ophthalmology; 1987 Apr; 94(4):425-34. PubMed ID: 3035453
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U).
Orellana J; Teich SA; Winterkorn JS; Mathur-Wagh U; Handwerger S; Schlamm H; Malamud SC; Yancovitz SR; Cederberg DM; Mildvan DS
Br J Ophthalmol; 1988 Jul; 72(7):525-9. PubMed ID: 2843219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
